Search results
Namita Thapar Opens Up About Work-Life Balance As Shark: “Taunted As Doing Part Time Job”
Mashable India· 6 days agoEmcure’s Namita Thapar appeared on Karishma Tanna’s latest podcast, ‘Rokda & Dokda’, opening up...
Shark Tank India’s Namita Thapar praises Karishma Tanna for breaking stereotypes; says ‘you have...
The Times of India· 2 days agoNamita Thapar of Shark Tank India lauded Karishma Tanna for shattering stereotypes and showcasing...
Shark Tank fame 'Phar-Maa' Namita Thapar to make 293x returns from Emcure IPO
Business Today· 7 days agoNamita Thapar, one of the sharks from Shark Tank India, is all set to offload her stake partially in...
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO
The Economic Times· 4 days agoShark Tank fame Namita Thapar, part of the promoter group of Emcure Pharmaceuticals, will make...
Exploring Shark Tank India fame Anupam Mittal’s lifestyle: From luxurious 6 BHK house to swanky cars
Pinkvilla· 6 days agoShark Tank India is one of its own kind of shows on national television. While Shark Tank India has...
Watch a Great White Shark Check Out a Paddleboarding T-Rex
The Inertia· 3 days agoA guy in a T-Rex suit on a paddleboard unwittingly cruised around with a great white shark. That's...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 3 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Shark Tank India: If you’re a fan of “Shark Tank India,” you’ll enjoy these other shows that delve...
The Times of India· 2 days agoEntrepreneurs pitch their business ideas to a panel of venture capitalists, affectionately referred...
Shark Tank India gearing up for season four - Times of India
The Times of India· 4 days agoAfter the phenomenal success of its first three seasons, Sony LIV is gearing up for the fourth...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 9 hours agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...